Questions regarding the design of the study of pulse versus oral cyclophosphamide in the treatment of Wegener's granulomatosis: comment on the article by Guillevin et al

Arthritis Rheum. 1998 Sep;41(9):1705-6; author reply 1707-9. doi: 10.1002/1529-0131(199809)41:9<1705::aid-art28>3.0.co;2-2.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Administration, Oral
  • Antirheumatic Agents / administration & dosage*
  • Antirheumatic Agents / adverse effects
  • Cyclophosphamide / administration & dosage*
  • Cyclophosphamide / adverse effects
  • Granulomatosis with Polyangiitis / drug therapy*
  • Humans
  • Injections, Intravenous
  • Randomized Controlled Trials as Topic
  • Research Design
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Cyclophosphamide